Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …

Neutrophilia and the production of neutrophil extracellular traps (NETs) are two of many
measures of increased inflammation in severe COVID-19 that also accompany its …

Background SARS-CoV-2 infects through the respiratory route and triggers inflammatory
response by affecting multiple cell types including type II alveolar epithelial cells. SARS-CoV …

The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …

Despite tremendous global efforts since the beginning of the COVID-19 pandemic, still only
a limited number of prophylactic and therapeutic options are available. Although vaccination …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
COVID-19, has infected> 600 million people in the ongoing global pandemic. Several …

SARS-CoV-2 pandemic is the current threat of the world with enormous number of
deceases. As most of the countries have constraints on resources, particularly for intensive …

While a certain level of inflammation is critical for humans to survive infection and injury, a
prolonged inflammatory response can have fatal consequences. Pattern recognition Toll-like …

In this study, biomimetic virus-like particles (VLPs) composed of superparamagnetic iron
oxide nanoparticles (SPIONs) and receptor binding domain (RBD) of the SARS-CoV-2 virus …

Respiratory viruses cause airway inflammation, resulting in epithelial injury and repair.
miRNAs, including miR-149-5p, regulate different pathological conditions. We aimed to …